4 hours Ago By Defense World Staff
Renaissance Technologies LLC increased its position in Stereotaxis, Inc. (NYSEAMERICAN:STXS – Free Report) by 12.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC).
The institutional investor owned 406,200 shares of the company’s stock after purchasing an additional 44,000 shares during the period. Renaissance Technologies LLC owned approximately 0.48% of Stereotaxis worth $926,000 at the end of the most recent reporting period.
A number of other hedge funds also recently bought and sold shares of STXS. State Street Corp raised its position in Stereotaxis by 5.7% in the 3rd quarter.
State Street Corp now owns 680,612 shares of the company’s stock worth $1,388,000 after buying an additional 36,518 shares during the last quarter. Jane Street Group LLC increased its position in shares of Stereotaxis by 26.9% during the 3rd quarter.
Jane Street Group LLC now owns 29,773 shares of the company’s stock valued at $61,000 after purchasing an additional 6,313 shares during the last quarter. Barclays PLC increased its position in shares of Stereotaxis by 449.9% during the 3rd quarter.
Barclays PLC now owns 101,953 shares of the company’s stock valued at $208,000 after purchasing an additional 83,412 shares during the last quarter. Geode Capital Management LLC increased its position in shares of Stereotaxis by 7.2% during the 3rd quarter.
Geode Capital Management LLC now owns 1,391,718 shares of the company’s stock valued at $2,840,000 after purchasing an additional 93,253 shares during the last quarter. Finally, SG Americas Securities LLC increased its position in shares of Stereotaxis by 39.2% during the 4th quarter.
SG Americas Securities LLC now owns 26,360 shares of the company’s stock valued at $60,000 after purchasing an additional 7,417 shares during the last quarter. Institutional investors own 45.35% of the company’s stock.
Insider Activity at StereotaxisIn other Stereotaxis news, Director Paul J. Isaac purchased 38,000 shares of the company’s stock in a transaction on Monday, March 10th. The stock was acquired at an average cost of $1.
81 per share, for a total transaction of $68,780.00. Following the purchase, the director now directly owns 87,299 shares of the company’s stock, valued at $158,011.
19. This trade represents a 77.08 % increase in their position.
The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 18.52% of the stock is currently owned by corporate insiders.
Stereotaxis Stock Down 1.0 %NYSEAMERICAN STXS opened at $2.00 on Thursday.
Stereotaxis, Inc. has a 52 week low of $1.54 and a 52 week high of $2.
72. The firm has a market capitalization of $169.46 million, a P/E ratio of -7.
14 and a beta of 1.54. The company has a 50-day moving average price of $1.
90 and a 200-day moving average price of $2.07. Stereotaxis Company Profile (Free Report)Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally.
Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.Read MoreFive stocks we like better than StereotaxisThe 3 Best Retail Stocks to Shop for in AugustWhy D-Wave’s Project With Davidson Is a Game-Changer For QuantumHow to buy stock: A step-by-step guide for beginners Hims & Hers Stock Soars on Novo Nordisk CollaborationHow to Calculate Retirement Income: MarketBeat’s CalculatorAmazon’s Earnings Will Make or Break the Stock’s Comeback.
